Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A 57-year-old man with IgG, ISS stage II multiple myeloma with normal cytogenetics was treated with vincristine/adriamycin/dexamethasone induction followed by autologous hematopoietic stem cell transplantation and achieved a very good partial response. The patient relapsed 4.5 years later and received bortezomib/dexamethasone treatment, which conferred a very good partial response once again.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi